- About Us
- Patient Information
|Advocacy and Policy|
Lymphedema Treatment Act
Unfortunately, the 115th Session of Congress ended without passage of The Lymphedema Treatment Act. The bill received 366 co-sponsors in the House and 66 co-sponsors in the Senate. On February 14, 2019, The Lymphedema Treatment Act (S.518) was reintroduced in the Senate by Maria Cantwell (D-WA) and Todd Young (R-IN). They were joined by 31 original co-sponsors. The House bill (H.R. 1948) has also been reintroduced by Rep. Jan Schakowsky (D-IL). The former House champion, Rep. Dave Reichert, retired last year, and Rep. Jan Schakowsky has been one of the co-leads for the past four years.
Compression therapy is considered the gold standard for the treatment of lymphedema and the treatment and prevention of venous leg ulcers (VLUs), also known as stasis ulcers. The WOCN Society strongly supports the Lymphedema Treatment Act; this legislation reflects the vision and core tenets of the Society as a means to support cost-effective, evidence-based prevention and treatment of complex wound conditions such as VLUs and lymphedema. Take action now!